HomeTMDX • NASDAQ
add
TransMedics Group Inc
Previous close
$142.30
Day range
$134.00 - $144.23
Year range
$36.42 - $144.23
Market cap
4.49B USD
Avg Volume
971.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 96.85M | 133.07% |
Operating expense | 47.54M | 54.08% |
Net income | 12.20M | 562.71% |
Net profit margin | 12.59 | 298.58% |
Earnings per share | 0.35 | 537.50% |
EBITDA | 16.72M | 2,185.16% |
Effective tax rate | 1.58% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 350.22M | 79.25% |
Total assets | 723.83M | 152.13% |
Total liabilities | 564.36M | 497.44% |
Total equity | 159.47M | — |
Shares outstanding | 32.94M | — |
Price to book | 29.34 | — |
Return on assets | 4.34% | — |
Return on capital | 4.67% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 12.20M | 562.71% |
Cash from operations | -3.44M | 60.34% |
Cash from investing | -44.17M | -4,665.05% |
Cash from financing | 3.18M | -19.53% |
Net change in cash | -44.60M | -702.50% |
Free cash flow | -54.49M | -580.12% |
About
Founded
1998
Headquarters
Website
Employees
584